Home » Healthcare » Europe Peritoneal Dialysis Market

Europe Peritoneal Dialysis Market By Type (Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)); By Product (Peritoneal Dialysis Machines, Peritoneal Dialysis Solutions, Dialysis Catheters, Others); By End User (Hospitals, Dialysis Centers, Home Care Settings) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Europe Peritoneal Dialysis Market Size 2023	USD 2,499.93 million
Europe Peritoneal Dialysis Market, CAGR	5.15%
Europe Peritoneal Dialysis Market Size 2032	USD 3,829.10 million

Market Overview

The Europe Peritoneal Dialysis Market is projected to grow from USD 2,499.93 million in 2023 to USD 3,829.10 million by 2032, at a CAGR of 5.15% during the forecast period.

The Europe peritoneal dialysis market is driven by the increasing prevalence of end-stage renal disease (ESRD) and a growing aging population susceptible to chronic kidney conditions. Technological advancements in dialysis equipment and solutions, coupled with rising awareness of home-based treatment options, further fuel market growth. Favorable reimbursement policies and government initiatives to promote peritoneal dialysis as a cost-effective alternative to hemodialysis also contribute to its adoption. Key trends include the development of automated peritoneal dialysis (APD) devices, enhancing patient convenience and compliance, and a focus on biocompatible solutions to reduce complications. Additionally, the integration of telemedicine and remote monitoring technologies into peritoneal dialysis care highlights a shift toward personalized and efficient treatment management. These factors collectively create a dynamic market landscape with opportunities for innovation and expanded adoption across Europe.

The Europe peritoneal dialysis market demonstrates significant growth across regions due to the increasing prevalence of chronic kidney diseases and the shift toward home-based treatments. Western European countries such as the UK, France, and Germany are at the forefront, driven by advanced healthcare systems, robust reimbursement policies, and the widespread adoption of automated peritoneal dialysis (APD) systems. Emerging markets in Southern and Eastern Europe, including Spain and Poland, are also witnessing rising demand as healthcare infrastructure improves. Key players driving the market include Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Baxter International Inc., Medtronic plc, and Nipro Corporation. These companies focus on innovation, offering advanced dialysis equipment and biocompatible solutions to meet the evolving needs of patients and healthcare providers. Their efforts, combined with growing awareness campaigns, are reshaping the landscape of peritoneal dialysis across Europe.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The Europe peritoneal dialysis market was valued at USD 2,499.93 million in 2023 and is projected to reach USD 3,829.10 million by 2032, growing at a CAGR of 5.15%.
The increasing prevalence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD) drives the demand for peritoneal dialysis across Europe.
Technological advancements, such as automated peritoneal dialysis (APD) systems, enhance patient convenience and improve treatment outcomes.
Key trends include the rise of home-based dialysis options and innovations in biocompatible solutions to improve patient care.
The market is highly competitive, with major players like Fresenius Medical Care, Baxter, and B. Braun leading the industry through advanced product offerings.
Market restraints include limited patient awareness, high initial equipment costs, and logistical challenges in rural areas.
Regional analysis shows strong growth in Western Europe, while emerging markets in Eastern and Southern Europe present untapped opportunities for expansion.

Market Drivers

Growing Prevalence of Kidney Diseases

The increasing incidence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD) is a primary driver of the Europe peritoneal dialysis market. With a rising number of patients requiring long-term renal replacement therapies, peritoneal dialysis has gained prominence as an effective treatment option. Lifestyle changes, the growing burden of diabetes, and hypertension further contribute to the prevalence of kidney-related disorders, boosting the demand for convenient and accessible dialysis solutions. For instance, a report by the European Kidney Health Alliance (EKHA) indicates that CKD affects approximately 75 million people in Europe. This trend underscores the critical need for peritoneal dialysis as a viable alternative to traditional hemodialysis methods.

Shift Toward Home-Based Treatment Options

The preference for home-based medical treatments, including dialysis, is on the rise due to its convenience and reduced burden on healthcare facilities. Peritoneal dialysis offers patients the flexibility to manage their treatment schedules, minimizing hospital visits and enhancing their quality of life. This shift aligns with evolving healthcare models that prioritize patient-centric care and cost-effective solutions. For instance, the Global Kidney Health Atlas 2023 highlights that the number of people initiating chronic peritoneal dialysis in Western Europe is 21 per million population. The adoption of home-based peritoneal dialysis is further supported by advancements in technology, such as portable dialysis systems and user-friendly equipment, which make self-administered care more feasible.

Supportive Reimbursement Policies and Government Initiatives

Favorable reimbursement frameworks and government initiatives are significant factors encouraging the adoption of peritoneal dialysis in Europe. Policies that subsidize treatment costs make peritoneal dialysis accessible to a broader patient base, particularly in countries with robust healthcare systems. For example, a report by Med Tech Reimbursement Consulting (MTRC) outlines the reimbursement situation for peritoneal dialysis in 11 EU countries, highlighting the support provided by public health insurance systems. Governments and healthcare organizations are also promoting awareness campaigns to educate patients and healthcare providers about the benefits of peritoneal dialysis, further driving its adoption across the region.

Technological Advancements in Dialysis Solutions

Innovation in dialysis equipment and solutions plays a pivotal role in driving market growth. Automated peritoneal dialysis (APD) systems, which offer enhanced patient compliance and improved efficiency, are gaining traction across Europe. Additionally, the development of biocompatible dialysis solutions aims to reduce complications and improve patient outcomes. These advancements, coupled with ongoing research and development initiatives, strengthen the market by addressing patient needs and fostering greater acceptance of peritoneal dialysis over other alternatives.

Market Trends

Increasing Awareness and Educational Initiatives

Awareness campaigns and educational programs about peritoneal dialysis are gaining momentum across Europe. Healthcare organizations and patient advocacy groups are collaborating to inform the public and medical professionals about the benefits of peritoneal dialysis, such as its cost-effectiveness and suitability for home-based care. For example, the International Society for Peritoneal Dialysis (ISPD) collaborates with various organizations to promote peritoneal dialysis through educational initiatives and awareness campaigns. These initiatives aim to dispel misconceptions, increase patient confidence, and drive broader acceptance of peritoneal dialysis as a reliable treatment option.

Rising Adoption of Automated Peritoneal Dialysis (APD) Systems

The increasing preference for automated peritoneal dialysis (APD) systems is a prominent trend in the Europe peritoneal dialysis market. These systems offer convenience by automating the dialysis process, typically performed overnight, thereby reducing the burden on patients and caregivers. APD enhances patient compliance and allows for a more flexible lifestyle compared to continuous ambulatory peritoneal dialysis (CAPD). The integration of advanced monitoring and alarm systems in APD devices ensures patient safety, further driving their adoption across the region.

Focus on Biocompatible Dialysis Solutions

The market is witnessing a shift toward the development and use of biocompatible peritoneal dialysis solutions. These solutions are formulated to minimize irritation and peritoneal membrane damage, which can occur with traditional dialysis fluids. By improving the biocompatibility of solutions, manufacturers aim to extend the effectiveness of peritoneal dialysis treatments and enhance patient outcomes. This trend reflects the growing emphasis on long-term treatment sustainability and the reduction of associated complications.

Integration of Telemedicine and Remote Monitoring

The integration of telemedicine and remote monitoring technologies into peritoneal dialysis care is transforming the market. These innovations enable real-time tracking of treatment parameters, allowing healthcare providers to address potential issues proactively. Remote monitoring not only enhances patient safety but also supports personalized treatment plans, improving the overall quality of care. This trend aligns with the broader push for digital healthcare solutions, which are becoming increasingly vital in managing chronic conditions such as kidney disease.

Market Challenges Analysis

Limited Patient Awareness and Misconceptions

A significant challenge in the Europe peritoneal dialysis market is the limited awareness among patients about this treatment option. Many patients and caregivers remain unfamiliar with the benefits of peritoneal dialysis, such as its suitability for home-based care and its ability to provide greater lifestyle flexibility compared to hemodialysis. Additionally, misconceptions about the complexity of self-administering peritoneal dialysis or concerns about infection risks deter many potential users. For instance, a survey by the European Renal Association found that only 13% of patients on renal replacement therapy were using peritoneal dialysis, indicating a lack of awareness and acceptance. These knowledge gaps hinder the adoption of peritoneal dialysis, particularly in regions with limited access to educational resources or patient support networks. Addressing this challenge requires robust awareness campaigns and enhanced communication between healthcare providers and patients.

Technical and Logistical Barriers

Technical and logistical barriers pose another challenge for the widespread adoption of peritoneal dialysis across Europe. Patients in rural or underserved areas often face difficulties in accessing necessary equipment, supplies, and technical support for home-based treatments. Furthermore, healthcare providers may lack adequate training to guide patients through the initiation and management of peritoneal dialysis. Supply chain disruptions and inconsistent availability of biocompatible solutions or automated systems exacerbate these challenges. These barriers highlight the need for investments in infrastructure, streamlined distribution networks, and comprehensive training programs to ensure equitable access to peritoneal dialysis care across all regions.

Market Opportunities

Expanding Home Healthcare Sector

The growing emphasis on home healthcare presents a significant opportunity for the Europe peritoneal dialysis market. With healthcare systems increasingly prioritizing patient-centric care models, home-based peritoneal dialysis aligns perfectly with this trend. It offers flexibility and convenience, enabling patients to manage their treatment schedules while reducing the need for frequent hospital visits. This is particularly appealing in aging populations across Europe, where the prevalence of chronic kidney diseases is high. The rise in government initiatives promoting home healthcare and the introduction of portable, easy-to-use peritoneal dialysis systems further drive this opportunity. Manufacturers and healthcare providers can capitalize on this trend by developing user-friendly solutions and enhancing patient education programs.

Technological Innovations and Digital Integration

Technological advancements and the integration of digital solutions into peritoneal dialysis care create vast opportunities for market growth. Automated peritoneal dialysis (APD) systems equipped with remote monitoring and telemedicine capabilities are transforming patient management by enabling real-time data sharing and personalized treatment adjustments. This reduces complications and enhances patient outcomes, fostering greater trust in peritoneal dialysis. Additionally, advancements in biocompatible dialysis fluids and materials offer the potential to address treatment-related complications, encouraging wider adoption. By focusing on innovation and collaborating with digital health companies, market players can meet evolving patient needs and expand their presence in the European market.

Market Segmentation Analysis:

By Type:

The Europe peritoneal dialysis market is segmented by type into Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). CAPD remains a widely adopted method due to its simplicity, affordability, and suitability for patients who prefer manual control over their dialysis routine. This segment caters primarily to individuals in regions with limited access to advanced healthcare infrastructure, offering an effective and low-cost treatment alternative. Conversely, APD is witnessing rapid growth due to its automated capabilities, enhanced convenience, and potential for better treatment outcomes. APD systems, often used during nighttime, allow patients to maintain an active lifestyle while reducing the frequency of hospital visits. The increasing adoption of APD reflects the broader shift towards home-based and patient-centric dialysis solutions across Europe.

By Product:

By product, the market encompasses peritoneal dialysis machines, peritoneal dialysis solutions, dialysis catheters, and other related products. Peritoneal dialysis solutions represent the largest segment, driven by their recurring demand and critical role in treatment efficacy. Innovations in biocompatible solutions are further enhancing patient outcomes, spurring market growth. Peritoneal dialysis machines, particularly automated models, are experiencing rising demand due to their convenience and integration with remote monitoring technologies. Dialysis catheters and ancillary products also hold significant market share, as they are essential for ensuring safe and effective treatment delivery. Collectively, these product segments highlight the market’s dynamic nature, fueled by advancements in technology and an increasing focus on improving patient care.

Segments:

Based on Type:

Continuous Ambulatory Peritoneal Dialysis (CAPD)
Automated Peritoneal Dialysis (APD)

Based on Product:

Peritoneal Dialysis Machines
Peritoneal Dialysis Solutions
Dialysis Catheters
Others

Based on End-user:

Hospitals
Dialysis Centers
Home Care Settings

Based on the Geography:

UK
France
Germany
Italy
Spain
Russia
Belgium
Netherlands
Austria
Sweden
Poland
Denmark
Switzerland
Rest of Europe

Regional Analysis

United Kingdom and France

The United Kingdom and France collectively hold a significant share of the Europe peritoneal dialysis market, accounting for over 30% of the total revenue. This dominance can be attributed to well-established healthcare infrastructures, high prevalence of chronic kidney diseases (CKD), and strong government support for home-based care. The UK, in particular, benefits from the National Health Service (NHS) initiatives that promote peritoneal dialysis as a cost-effective alternative to hemodialysis. France, on the other hand, is experiencing growth due to rising adoption of automated peritoneal dialysis (APD) systems and increasing awareness of its benefits among patients and healthcare professionals. Both countries emphasize technological advancements and patient education, further driving market expansion.

Germany

Germany holds approximately 20% of the Europe peritoneal dialysis market share, driven by its robust healthcare system and significant investments in medical technology. The country is a hub for innovation, with leading manufacturers introducing cutting-edge peritoneal dialysis equipment and solutions. Automated systems and biocompatible dialysis solutions are gaining traction among German patients, supported by comprehensive insurance coverage and reimbursement policies. Additionally, Germany’s aging population and rising prevalence of end-stage renal disease (ESRD) are increasing the demand for home-based dialysis options, solidifying its position as a key market player in Europe.

Italy and Spain

Italy and Spain collectively contribute to around 15% of the market share, showcasing notable growth potential due to increasing healthcare awareness and investments. Both countries are witnessing a gradual shift from hospital-based hemodialysis to home-based peritoneal dialysis, spurred by government initiatives and cost-efficiency considerations. In Spain, the growing adoption of APD systems highlights the trend towards patient-centric care. Italy, with its aging demographic and high prevalence of CKD, is also focusing on enhancing access to peritoneal dialysis treatments. However, limited patient awareness and logistical challenges in rural areas remain hurdles that require attention to unlock the full potential of these markets.

Rest of Europe

The Rest of Europe, including countries like Austria, Switzerland, Denmark, and Sweden, accounts for nearly 35% of the regional market share. These markets are characterized by high healthcare standards, supportive policies, and increasing adoption of advanced dialysis solutions. Switzerland and Sweden, in particular, are pioneers in adopting telemedicine-integrated APD systems, enhancing patient monitoring and treatment efficacy. Eastern European countries, including Poland and Russia, are emerging as growth hotspots due to improving healthcare infrastructure and rising awareness of peritoneal dialysis benefits. The region offers untapped opportunities for market players focusing on expanding their presence in underserved areas.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Fresenius Medical Care AG & Co. KGaA
Braun Melsungen AG
Nipro Corporation
Baxter International Inc.
Medtronic plc
Diaverum AB
Gambro (Fresenius Medical Care)
Vifor Pharma
Nikkiso Europe GmbH
Hemotech

Competitive Analysis

The Europe peritoneal dialysis market is highly competitive, with leading players continuously innovating and expanding their product offerings. Companies like Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Baxter International Inc., Medtronic plc, Nipro Corporation, Diaverum AB, Gambro (Fresenius Medical Care), Vifor Pharma, Nikkiso Europe GmbH, and Hemotech are prominent in the region. Market leaders focus on innovation, offering advanced peritoneal dialysis systems, biocompatible solutions, and patient-centric technologies to meet evolving healthcare demands. For instance, a report by the European Renal Association highlights that the adoption of automated peritoneal dialysis (APD) systems has significantly improved patient compliance and reduced the burden on healthcare facilities. Automated peritoneal dialysis (APD) systems with remote monitoring capabilities are a key area of development, enabling enhanced patient care and treatment outcomes. Strategic initiatives such as product launches, partnerships, and acquisitions play a crucial role in expanding market share. Companies emphasize improving manufacturing capabilities and expanding their geographic reach, particularly in emerging markets with growing healthcare infrastructure. Furthermore, competitive differentiation is driven by the integration of digital health solutions, enabling real-time data tracking and telemedicine support for dialysis patients. These advancements not only enhance patient convenience but also address logistical challenges, positioning the market for sustained growth amidst rising demand for home-based dialysis treatments.

Recent Developments

In August 2024, Baxter International Inc (US) and Carlyle (US) signed a definitive agreement under which Carlyle will acquire Baxter’s Kidney Care segment. The segment will be named Vantive, with the aim of creating a standalone kidney care company.

In April 2023, Medtronic plc (Ireland) and DaVita Inc (US) launched Mozarc Medical—an independent new company that aims to reshape kidney health and drive patient-centered technology solutions.

In August 2022, Fresenius Medical Care AG (Germany) acquired InterWell Health (US), a physician organization that drives innovation in the kidney care space in the US, and Cricket Health. Inc (US), provider of value-based kidney care with patient engagement and data platform.

Market Concentration & Characteristics

The Europe peritoneal dialysis market exhibits a moderate to high level of concentration, with a few key players dominating the industry. These companies leverage their extensive product portfolios, technological advancements, and established distribution networks to maintain a competitive edge. Market concentration is particularly evident in automated peritoneal dialysis (APD) systems and biocompatible solutions, where innovation plays a critical role in differentiating offerings. Despite the dominance of leading firms, smaller players and regional companies are gradually gaining traction by addressing specific market needs, such as affordability and accessibility in underserved regions. The market’s characteristics reflect a strong emphasis on home-based dialysis solutions, driven by the growing demand for patient-centric care and cost-efficient treatments. Regulatory frameworks across Europe support the adoption of advanced peritoneal dialysis systems, ensuring safety and efficacy. Additionally, the market is shaped by trends such as digital integration, enabling remote monitoring and personalized treatment adjustments. However, logistical challenges and the need for extensive patient education remain key factors influencing market dynamics. Overall, the Europe peritoneal dialysis market is marked by a combination of innovation-driven competition and evolving patient needs, creating opportunities for growth and development across various segments.

Report Coverage

The research report offers an in-depth analysis based on Type, Product, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The Europe peritoneal dialysis market is expected to witness steady growth driven by the rising prevalence of chronic kidney diseases.
Increased adoption of automated peritoneal dialysis (APD) systems will enhance patient convenience and treatment outcomes.
Innovations in biocompatible dialysis solutions will further improve patient safety and efficacy of treatments.
Home-based dialysis treatments are projected to gain significant traction due to cost efficiency and patient-centric approaches.
Digital health integration, including remote monitoring, will play a pivotal role in advancing personalized dialysis care.
Emerging markets in Southern and Eastern Europe will offer substantial growth opportunities due to improving healthcare infrastructure.
Enhanced patient education and awareness campaigns will drive wider acceptance of peritoneal dialysis.
Strategic collaborations and acquisitions among key players will accelerate the introduction of advanced technologies.
Regulatory support and favorable reimbursement policies will encourage the adoption of peritoneal dialysis systems.
Continued investments in research and development will shape the future landscape of the Europe peritoneal dialysis market.

CHAPTER NO. 1 : INTRODUCTION 19

1.1.1. Report Description 19

Purpose of the Report 19

USP & Key Offerings 19

1.1.2. Key Benefits for Stakeholders 19

1.1.3. Target Audience 20

1.1.4. Report Scope 20

CHAPTER NO. 2 : EXECUTIVE SUMMARY 21

2.1. Peritoneal Dialysis Market Snapshot 21

2.1.1. Europe Peritoneal Dialysis Market, 2018 – 2032 (USD Million) 22

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 23

3.1. Russia-Ukraine and Israel-Palestine War Impacts 23

CHAPTER NO. 4 : PERITONEAL DIALYSIS MARKET – INDUSTRY ANALYSIS 24

4.1. Introduction 24

4.2. Market Drivers 25

4.2.1. Rising prevalence of chronic kidney diseases (CKD) 25

4.2.2. Growing adoption of home dialysis treatments 26

4.3. Market Restraints 27

4.3.1. High cost of peritoneal dialysis equipment and treatments 27

4.4. Market Opportunities 28

4.4.1. Technological advancements in automated dialysis systems 28

4.5. Porter’s Five Forces Analysis 29

4.6. Buying Criteria 30

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 31

5.1. Import Analysis by Europe 31

5.1.1. Europe Peritoneal Dialysis Market Import Volume/Revenue, By Europe, 2018 – 2023 31

5.2. Export Analysis by Europe 32

5.2.1. Europe Peritoneal Dialysis Market Export Volume/Revenue, By Europe, 2018 – 2023 32

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 33

6.1. Demand Analysis by Europe 33

6.1.1. Europe Peritoneal Dialysis Market Demand Volume/Revenue, By Europe, 2018 – 2023 33

6.2. Supply Analysis by Europe 34

6.2.1. Europe Peritoneal Dialysis Market Supply Volume/Revenue, By Europe, 2018 – 2023 34

CHAPTER NO. 7 : PRODUCTION ANALYSIS 35

7.1. Production Analysis by Europe 35

7.1.1. Europe Peritoneal Dialysis Market Production Volume/Revenue, By Europe, 2018 – 2023 35

CHAPTER NO. 8 : PRICE ANALYSIS 36

8.1. Price Analysis by Type 36

8.1.1. Europe Peritoneal Dialysis Market Price, By Type, 2018 – 2023 36

8.1.2. Europe Type Market Price, By Type, 2018 – 2023 36

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 37

9.1. Key Raw Materials and Suppliers 37

9.2. Key Raw Materials Price Trend 37

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 38

10.1. Manufacturing Cost Analysis 38

10.2. Manufacturing Process 38

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 39

11.1. Company Market Share Analysis – 2023 39

11.2. Value Chain Analysis 39

11.2.1. Europe Peritoneal Dialysis Market: Company Market Share, by Volume, 2023 40

11.2.2. Europe Peritoneal Dialysis Market: Company Market Share, by Revenue, 2023 41

11.2.3. Europe Peritoneal Dialysis Market: Top 6 Company Market Share, by Revenue, 2023 41

11.2.4. Europe Peritoneal Dialysis Market: Top 3 Company Market Share, by Revenue, 2023 42

11.3. Europe Peritoneal Dialysis Market Company Volume Market Share, 2023 43

11.4. Europe Peritoneal Dialysis Market Company Revenue Market Share, 2023 44

11.5. Company Assessment Metrics, 2023 44

11.5.1. Stars 44

11.5.2. Emerging Leaders 44

11.5.3. Pervasive Players 44

11.5.4. Participants 44

11.6. Start-ups /SMEs Assessment Metrics, 2023 44

11.6.1. Progressive Companies 44

11.6.2. Responsive Companies 45

11.6.3. Dynamic Companies 45

11.6.4. Starting Blocks 45

11.7. Strategic Developments 46

11.7.1. Acquisitions & Mergers 46

New Product Launch 46

Europe Expansion 46

11.8. Key Players Product Matrix 47

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 48

12.1. PESTEL 48

12.1.1. Political Factors 48

12.1.2. Economic Factors 48

12.1.3. Social Factors 48

12.1.4. Technological Factors 48

12.1.5. Environmental Factors 48

12.1.6. Legal Factors 48

12.2. Adjacent Market Analysis 48

CHAPTER NO. 13 : PERITONEAL DIALYSIS MARKET – BY TYPE SEGMENT ANALYSIS 49

13.1. Peritoneal Dialysis Market Overview, by Type Segment 49

13.1.1. Peritoneal Dialysis Market Revenue Share, By Type, 2023 & 2032 50

13.1.2. Peritoneal Dialysis Market Attractiveness Analysis, By Type 51

13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 51

13.1.4. Peritoneal Dialysis Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

13.2. Continuous Ambulatory Peritoneal Dialysis (CAPD) 53

13.3. Automated Peritoneal Dialysis (APD) 54

CHAPTER NO. 14 : PERITONEAL DIALYSIS MARKET – BY PRODUCT SEGMENT ANALYSIS 55

14.1. Peritoneal Dialysis Market Overview, by Product Segment 55

14.1.1. Peritoneal Dialysis Market Revenue Share, By Product, 2023 & 2032 56

14.1.2. Peritoneal Dialysis Market Attractiveness Analysis, By Product 57

14.1.3. Incremental Revenue Growth Opportunity, by Product, 2024 – 2032 57

14.1.4. Peritoneal Dialysis Market Revenue, By Product, 2018, 2023, 2027 & 2032 58

14.2. Peritoneal Dialysis Machines 59

14.3. Peritoneal Dialysis Solutions 60

14.4. Dialysis Catheters 61

14.5. Others 62

CHAPTER NO. 15 : PERITONEAL DIALYSIS MARKET – BY END-USER SEGMENT ANALYSIS 63

15.1. Peritoneal Dialysis Market Overview, by End-user Segment 63

15.1.1. Peritoneal Dialysis Market Revenue Share, By End-user, 2023 & 2032 64

15.1.2. Peritoneal Dialysis Market Attractiveness Analysis, By End-user 65

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 65

15.1.4. Peritoneal Dialysis Market Revenue, By End-user, 2018, 2023, 2027 & 2032 66

15.2. Hospitals 67

15.3. Dialysis Centers 68

15.4. Home Care Settings 69

CHAPTER NO. 16 : PERITONEAL DIALYSIS MARKET – EUROPE ANALYSIS 70

16.1. Type 70

16.1.1. Europe Peritoneal Dialysis Market Revenue, By Type, 2018 – 2023 (USD Million) 70

16.2. Europe Peritoneal Dialysis Market Revenue, By Type, 2024 – 2032 (USD Million) 70

16.3. Product 71

16.3.1. Europe Peritoneal Dialysis Market Revenue, By Product, 2018 – 2023 (USD Million) 71

16.3.2. Europe Peritoneal Dialysis Market Revenue, By Product, 2024 – 2032 (USD Million) 71

16.4. End-user 72

16.4.1. Europe Peritoneal Dialysis Market Revenue, By End-user, 2018 – 2023 (USD Million) 72

16.4.2. Europe Peritoneal Dialysis Market Revenue, By End-user, 2024 – 2032 (USD Million) 72

16.5. UK 72

16.6. France 72

16.7. Germany 72

16.8. Italy 72

16.9. Spain 72

16.10. Russia 72

16.11. Belgium 72

16.12. Netherland 72

16.13. Austria 72

16.14. Sweden 73

16.15. Poland 73

16.16. Denmark 73

16.17. Switzerland 73

16.18. Rest of Europe 73

CHAPTER NO. 17 : COMPANY PROFILES 74

17.1. Fresenius Medical Care AG & Co. KGaA 74

17.1.1. Company Overview 74

17.1.2. Product Portfolio 74

17.1.3. Swot Analysis 74

17.1.4. Business Strategy 75

17.1.5. Financial Overview 75

17.2. B. Braun Melsungen AG 76

17.3. Nipro Corporation 76

17.4. Baxter International Inc. 76

17.5. Medtronic plc 76

17.6. Diaverum AB 76

17.7. Gambro (Fresenius Medical Care) 76

17.8. Vifor Pharma 76

17.9. Nikkiso Europe GmbH 76

17.10. Hemotech 76

List of Figures

FIG NO. 1. Europe Peritoneal Dialysis Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for Europe Peritoneal Dialysis Market 29

FIG NO. 3. Europe Peritoneal Dialysis Market Import Volume/Revenue, By Europe, 2018 – 2023 31

FIG NO. 4. Europe Peritoneal Dialysis Market Export Volume/Revenue, By Europe, 2018 – 2023 32

FIG NO. 5. Europe Peritoneal Dialysis Market Demand Volume/Revenue, By Europe, 2018 – 2023 33

FIG NO. 6. Europe Peritoneal Dialysis Market Supply Volume/Revenue, By Europe, 2018 – 2023 34

FIG NO. 7. Europe Peritoneal Dialysis Market Production Volume/Revenue, By Europe, 2018 – 2023 35

FIG NO. 8. Europe Peritoneal Dialysis Market Price, By Type, 2018 – 2023 36

FIG NO. 9. Raw Materials Price Trend Analysis, 2018 – 2023 37

FIG NO. 10. Manufacturing Cost Analysis 38

FIG NO. 11. Manufacturing Process 38

FIG NO. 12. Value Chain Analysis for Europe Peritoneal Dialysis Market 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. Peritoneal Dialysis Market – Company Volume Market Share, 2023 43

FIG NO. 18. Peritoneal Dialysis Market – Company Revenue Market Share, 2023 44

FIG NO. 19. Peritoneal Dialysis Market Revenue Share, By Type, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Type 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51

FIG NO. 22. Peritoneal Dialysis Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

FIG NO. 23. Europe Peritoneal Dialysis Market for Continuous Ambulatory Peritoneal Dialysis (CAPD), Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. Europe Peritoneal Dialysis Market for Automated Peritoneal Dialysis (APD), Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. Peritoneal Dialysis Market Revenue Share, By Product, 2023 & 2032 56

FIG NO. 26. Market Attractiveness Analysis, By Product 57

FIG NO. 27. Incremental Revenue Growth Opportunity by Product, 2024 – 2032 57

FIG NO. 28. Peritoneal Dialysis Market Revenue, By Product, 2018, 2023, 2027 & 2032 58

FIG NO. 29. Europe Peritoneal Dialysis Market for Peritoneal Dialysis Machines, Revenue (USD Million) 2018 – 2032 59

FIG NO. 30. Europe Peritoneal Dialysis Market for Peritoneal Dialysis Solutions, Revenue (USD Million) 2018 – 2032 60

FIG NO. 31. Europe Peritoneal Dialysis Market for Dialysis Catheters, Revenue (USD Million) 2018 – 2032 61

FIG NO. 32. Europe Peritoneal Dialysis Market for Others, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. Peritoneal Dialysis Market Revenue Share, By End-user, 2023 & 2032 64

FIG NO. 34. Market Attractiveness Analysis, By End-user 65

FIG NO. 35. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 65

FIG NO. 36. Peritoneal Dialysis Market Revenue, By End-user, 2018, 2023, 2027 & 2032 66

FIG NO. 37. Europe Peritoneal Dialysis Market for Hospitals, Revenue (USD Million) 2018 – 2032 67

FIG NO. 38. Europe Peritoneal Dialysis Market for Dialysis Centers, Revenue (USD Million) 2018 – 2032 68

FIG NO. 39. Europe Peritoneal Dialysis Market for Home Care Settings, Revenue (USD Million) 2018 – 2032 69

List of Tables

TABLE NO. 1. : Europe Peritoneal Dialysis Market: Snapshot 21

TABLE NO. 2. : Drivers for the Peritoneal Dialysis Market: Impact Analysis 25

TABLE NO. 3. : Restraints for the Peritoneal Dialysis Market: Impact Analysis 27

TABLE NO. 4. : Europe Peritoneal Dialysis Market Revenue, By Type, 2018 – 2023 36

TABLE NO. 5. : Key Raw Materials & Suppliers 37

TABLE NO. 6. : Europe Peritoneal Dialysis Market Revenue, By Type, 2018 – 2023 (USD Million) 70

TABLE NO. 7. : Europe Peritoneal Dialysis Market Revenue, By Type, 2024 – 2032 (USD Million) 70

TABLE NO. 8. : Europe Peritoneal Dialysis Market Revenue, By Product, 2018 – 2023 (USD Million) 71

TABLE NO. 9. : Europe Peritoneal Dialysis Market Revenue, By Product, 2024 – 2032 (USD Million) 71

TABLE NO. 10. : Europe Peritoneal Dialysis Market Revenue, By End-user, 2018 – 2023 (USD Million) 72

TABLE NO. 11. : Europe Peritoneal Dialysis Market Revenue, By End-user, 2024 – 2032 (USD Million) 72

Frequently Asked Questions

What is the current size of the Europe Peritoneal Dialysis market?

The Europe Peritoneal Dialysis market was valued at USD 2,499.93 million in 2023 and is projected to reach USD 3,829.10 million by 2032, growing at a compound annual growth rate (CAGR) of 5.15% during the forecast period.

What factors are driving the growth of the Europe Peritoneal Dialysis market?

The market’s growth is driven by the increasing prevalence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD), a growing aging population, and a shift toward home-based dialysis treatments. Technological advancements, such as automated peritoneal dialysis (APD) systems, and favorable reimbursement policies across Europe further contribute to the market’s expansion.

What are the key segments within the Europe Peritoneal Dialysis market?

The market is segmented by type into Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). It is further segmented by product into peritoneal dialysis machines, dialysis solutions, dialysis catheters, and other accessories. End-user segments include hospitals, dialysis centers, and home care settings, while regional segmentation covers countries like the UK, France, Germany, Italy, Spain, and emerging markets in Southern and Eastern Europe.

What are some challenges faced by the Europe Peritoneal Dialysis market?

Challenges include limited patient awareness about peritoneal dialysis and misconceptions regarding its complexity and safety. Technical and logistical barriers, such as inconsistent access to equipment and supplies in rural areas, also hinder adoption. These challenges necessitate enhanced educational efforts and infrastructure development to expand market reach.

Who are the major players in the Europe Peritoneal Dialysis market?

Key players in the market include Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Baxter International Inc., Medtronic plc, and Nipro Corporation. These companies focus on innovation, offering advanced dialysis systems and biocompatible solutions, and driving the market with strategic initiatives and partnerships.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –